Freight carrier Old Dominion (NASDAQ:ODFL) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.7% year on year to $1.31 billion. Its non-GAAP profit of $1.09 per share was 2.8% above analysts’ consensus estimates.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 42.6% year on year to $19.29 billion. The company’s full-year revenue guidance of $81.5 billion at the midpoint came in

Nasdaq’s fourth quarter exceeded Wall Street’s expectations, with management attributing the strong performance to robust growth in its solutions businesses and record activity across its U.S. and European exchanges. CEO Adena Friedman pointed to mileston

Dental technology company Align Technology (NASDAQ:ALGN) announced better-than-expected revenue in Q4 CY2025, with sales up 5.3% year on year to $1.05 billion. The company expects next quarter’s revenue to be around $1.02 billion, close to analysts’ estim

Investment management firm T. Rowe Price (NASDAQ:TROW) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.4% year on year to $1.94 billion. Its non-GAAP profit of $2.44 per share was 1% below analysts’ consensus estimates.

Food distribution giant Performance Food Group (NYSE:PFGC) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.2% year on year to $16.44 billion. On the other hand, next quarter’s revenue guidance of $16.15 billion was less impressive, co

Newspaper and digital media company The New York Times (NYSE:NYT) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $802.3 million. Its non-GAAP profit of $0.89 per share was in line with analysts’ cons

Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per share was 5.8% above analysts’ consensus estimates.

Medical device company Boston Scientific (NYSE:BSX) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The company expects next quarter’s revenue to be around $5.19 billion, close to analysts’ estimates

Investment banking firm Evercore (NYSE:EVR) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 32.4% year on year to $1.30 billion. Its non-GAAP profit of $5.13 per share was 26.7% above analysts’ consensus estimates.

Investment banking firm Moelis & Company (NYSE:MC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.2% year on year to $487.9 million. Its non-GAAP profit of $1.13 per share was 35.4% above analysts’ consensus estima

Household products company Reynolds (NASDAQ:REYN) announced better-than-expected revenue in Q4 CY2025, with sales up 1.3% year on year to $1.03 billion. On the other hand, next quarter’s revenue guidance of $809.8 million was less impressive, coming in 3.

Materials and photonics company Coherent (NYSE:COHR) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 17.5% year on year to $1.69 billion. On top of that, next quarter’s revenue guidance ($1.77 billion at the midpoint) was

Business development company Oaktree Specialty Lending (NASDAQ:OCSL) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 13.3% year on year to $75.1 million. Its non-GAAP profit of $0.41 per share was 8.8% above analysts’ consensus esti

IT solutions provider CDW (NASDAQGS:CDW) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.3% year on year to $5.51 billion. Its non-GAAP profit of $2.57 per share was 5.1% above analysts’ consensus estimates.